Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Lupin Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500257
ISIN Demat	INE326A01037
Book Value	531.58

NSE Code	LUPIN
Dividend Yield %	0.61
Market Cap	906581.50

P/E	22.82
EPS	86.99
Face Value	2


	BSE		NSE

04-Jul-2025 14:29

Last Price	1984.60
Net Change	29
% Change	1.48%
Prev.Close	1955.60
Open	1963.00
High	1995.70
Low	1957.15
Volume	38352

Last Price	1979.70
Net Change	24.9
% Change	1.27%
Prev.Close	1954.80
Open	1962.00
High	1996.00
Low	1957.00
Volume	639314

Value	76113379.2
Best Buy	1984.60
Best Sell	1986.05
Best Quantity	3
Sell Quantity	7
Today's Range	1995.70
52-Week High	2403.45
52-Week Low	1645.00

Value	1265649925.8
Best Buy	1979.20
Best Sell	1980.30
Best Quantity	25
Sell Quantity	16
Today's Range	1996.00
52-Week High	2402.90
52-Week Low	1651.15

Open Price	1959.80
High Price	1996.90
Low Price	1956.20
Last Price	1981.30
Prev Close	1953.70
Change	27.60
% Change	1.41 %

Average Price	1983.22
Underlying Value	1983.60
Number of contracts traded	4663
Turnover in Rs. Lakhs	39303
Open Interest	11084850.00
Change in O I	178500.00
% Change in O I	1.64 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	3
Price	1984.60

Quantity	7
Price	1986.05

Best Bid

Best Offer

Quantity	25
Price	1979.20

Quantity	16
Price	1980.30

Best Bid

Best Offer

Quantity	425
Price	1980.9

Quantity	425
Price	1981.6

Holding Details

Latest Corporate Events

Bonus

1 : 1

11-Aug-06

Book Closure

05-Aug-20

12-Aug-20

Dividend

400 %

16-Jul-24

Company News

02-07-2025

Lupin gets USFDA’s nod fo...

02-07-2025

Lupin moves up on getting...

01-07-2025

Lupin executes BTA for tr...

01-07-2025

Lupin executes BTA for tr...

26-06-2025

Lupin launches Prucalopri...

25-06-2025

Lupin gets USFDA’s nod fo...

25-06-2025

Lupin rises on getting US...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.